Re: Using Medicare Claims to Examine Long-Term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial

MJ Resnick - Journal of Urology, 2018 - journals.lww.com
Editorial Comment: The Prostate Cancer Prevention Trial (PCPT) identified a 25% decrease
in the risk of prostate cancer following 7 years of finasteride treatment. Since the study was …
相关文章

[引用][C] Re: Using Medicare Claims to Examine Long-Term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial

MJ Resnick - The Journal of urology, 2018 - pubmed.ncbi.nlm.nih.gov

[引用][C] Re: Using Medicare Claims to Examine Long-Term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

MJ Resnick - The Journal of Urology, 2018 - europepmc.org
Re: Using Medicare Claims to Examine Long-Term Prostate Cancer Risk of Finasteride in the
Prostate Cancer Prevention Trial. - Abstract - Europe PMC Sign in | Create an account …

[引用][C] Re: Using Medicare Claims to Examine Long-Term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial

MJ Resnick - The Journal of Urology, 2018 - auajournals.org
Re: Using Medicare Claims to Examine Long-Term Prostate Cancer Risk of Finasteride in the
Prostate Cancer Prevention Trial | Journal of Urology AUA Journals The Journal of Urology …